305 related articles for article (PubMed ID: 37222479)
1. Nano-based ocular drug delivery systems: an insight into the preclinical/clinical studies and their potential in the treatment of posterior ocular diseases.
Su Y; Fan X; Pang Y
Biomater Sci; 2023 Jun; 11(13):4490-4507. PubMed ID: 37222479
[TBL] [Abstract][Full Text] [Related]
2. Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases.
Durgun ME; Güngör S; Özsoy Y
J Ocul Pharmacol Ther; 2020; 36(6):323-341. PubMed ID: 32310723
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in topical nano drug-delivery systems for the anterior ocular segment.
Lakhani P; Patil A; Majumdar S
Ther Deliv; 2018 Feb; 9(2):137-153. PubMed ID: 29325511
[TBL] [Abstract][Full Text] [Related]
4. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; du Toit LC
J Pharm Sci; 2010 May; 99(5):2219-39. PubMed ID: 19894268
[TBL] [Abstract][Full Text] [Related]
5. Advances in ocular drug delivery.
Rawas-Qalaji M; Williams CA
Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004
[TBL] [Abstract][Full Text] [Related]
6. Nano-based eye drop: Topical and noninvasive therapy for ocular diseases.
Wang C; Pang Y
Adv Drug Deliv Rev; 2023 Mar; 194():114721. PubMed ID: 36773886
[TBL] [Abstract][Full Text] [Related]
7. Advances and limitations of drug delivery systems formulated as eye drops.
Jumelle C; Gholizadeh S; Annabi N; Dana R
J Control Release; 2020 May; 321():1-22. PubMed ID: 32027938
[TBL] [Abstract][Full Text] [Related]
8. Application of lipid nanoparticles to ocular drug delivery.
Battaglia L; Serpe L; Foglietta F; Muntoni E; Gallarate M; Del Pozo Rodriguez A; Solinis MA
Expert Opin Drug Deliv; 2016 Dec; 13(12):1743-1757. PubMed ID: 27291069
[TBL] [Abstract][Full Text] [Related]
9. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics.
Datta D; Priyanka Bandi S; Colaco V; Dhas N; Siva Reddy DV; Vora LK
Int J Pharm; 2024 Jun; 658():124192. PubMed ID: 38703931
[TBL] [Abstract][Full Text] [Related]
10. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.
Onugwu AL; Nwagwu CS; Onugwu OS; Echezona AC; Agbo CP; Ihim SA; Emeh P; Nnamani PO; Attama AA; Khutoryanskiy VV
J Control Release; 2023 Feb; 354():465-488. PubMed ID: 36642250
[TBL] [Abstract][Full Text] [Related]
11. Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.
Fangueiro JF; Veiga F; Silva AM; Souto EB
Curr Pharm Des; 2016; 22(9):1135-46. PubMed ID: 26675225
[TBL] [Abstract][Full Text] [Related]
12. A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances.
Wang R; Gao Y; Liu A; Zhai G
J Drug Target; 2021 Aug; 29(7):687-702. PubMed ID: 33474998
[TBL] [Abstract][Full Text] [Related]
13. Triamcinolone-loaded self nano-emulsifying drug delivery systems for ocular use: An alternative to invasive ocular surgeries and injections.
Dehghani M; Zahir-Jouzdani F; Shahbaz S; Andarzbakhsh K; Dinarvand S; Fathian Nasab MH; Asadi Amoli F; Asgharian R; Atyabi F
Int J Pharm; 2024 Mar; 653():123840. PubMed ID: 38262585
[TBL] [Abstract][Full Text] [Related]
14. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
Myles ME; Neumann DM; Hill JM
Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884
[TBL] [Abstract][Full Text] [Related]
15. Drug delivery to the posterior segment of the eye.
Fischer N; Narayanan R; Loewenstein A; Kuppermann BD
Eur J Ophthalmol; 2011; 21 Suppl 6():S20-6. PubMed ID: 23264325
[TBL] [Abstract][Full Text] [Related]
16. Minimally invasive microneedles for ocular drug delivery.
Thakur Singh RR; Tekko I; McAvoy K; McMillan H; Jones D; Donnelly RF
Expert Opin Drug Deliv; 2017 Apr; 14(4):525-537. PubMed ID: 27485251
[TBL] [Abstract][Full Text] [Related]
17. Cell penetrating peptides in ocular drug delivery: State of the art.
Pescina S; Ostacolo C; Gomez-Monterrey IM; Sala M; Bertamino A; Sonvico F; Padula C; Santi P; Bianchera A; Nicoli S
J Control Release; 2018 Aug; 284():84-102. PubMed ID: 29913221
[TBL] [Abstract][Full Text] [Related]
18. Hydrogels-based ophthalmic drug delivery systems for treatment of ocular diseases.
Fang G; Yang X; Wang Q; Zhang A; Tang B
Mater Sci Eng C Mater Biol Appl; 2021 Aug; 127():112212. PubMed ID: 34225864
[TBL] [Abstract][Full Text] [Related]
19. A New Direction in Ophthalmic Development: Nanoparticle Drug Delivery Systems.
Andonova VY
Curr Pharm Des; 2016; 22(41):6313-6329. PubMed ID: 27526789
[TBL] [Abstract][Full Text] [Related]
20. Novel drug delivery systems for ocular therapy: With special reference to liposomal ocular delivery.
Bhattacharjee A; Das PJ; Adhikari P; Marbaniang D; Pal P; Ray S; Mazumder B
Eur J Ophthalmol; 2019 Jan; 29(1):113-126. PubMed ID: 29756507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
